Analysis: As Sen. Bernie Sanders takes the gavel of the chamber’s prestigious health panel, a hearing on Medicare-for-all isn’t at the top of his list. He plans to instead push to move “very aggressively” on the high cost of prescription drugs.
You might not have guessed this: As Sen.takes the gavel of the chamber’s prestigious health panel, a hearing on Medicare-for-all isn’t at the top of his list.
this Congress, he’s acutely aware that the policy is nowhere near close to having enough support to pass this year, though he will still introduce and publicly discuss the measure.From the top of his new health perch, Sanders plans to instead push to move “very aggressively” on the high cost of prescription drugs, saying there’s an “incredible level of greed” within the pharmaceutical industry.
The 81-year-old plans to prove skeptics wrong by sitting down and talking with every lawmaker on his committee about their priorities, and said he’s already begun discussions with Cassidy. “Look, there are areas where there's not going to be bipartisan support,” Sanders said.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Senate 2024: Here are the Senate Democrats who may retire in next election cycleAs lawmakers prepare for what is likely to be a tough election cycle in 2024, many Senate Democrats in key battleground states are considering retirement as the party seeks to defend its slim majority in the upper chamber.
Read more »
Sen. Bernie Sanders urges Moderna not to hike price of Covid-19 vaccinesSanders, the incoming chair of the Senate health committee, called the price increase 'outrageous' in a letter to Moderna CEO Stephane Bancel.
Read more »
Vermont Sen. Bernie Sanders asks Moderna to not raise the price of its COVID-19 vaccineBernie Sanders asked Moderna to not raise the price of its COVID-19 vaccine in a letter this week. He is worried a price increase will make the vaccine too expensive for many Americans.
Read more »
Analysis | Ukraine sees ‘year of victory’ but Russia has other plansAnalysis: A decisive year looms for Russia’s war in Ukraine as Moscow’s forces dig in for a long fight.
Read more »
USD/CHF Price Analysis: Drops and invalidates falling wedge, seesaw around 0.9200The USD/CHF drops back beneath a falling wedge top-trendline and extends its losses for two consecutive trading days, down by 0.73% as the US Dollar (
Read more »
EUR/USD Price Analysis: Breakout traders triggered long, bears looking to pounceEUR/USD broke to the backside of the bearish trend at the end of last year. It has since rallied towards a key resistance area but has started to slow
Read more »